Michael Henderson
Board Member
Spyre Therapeutics, Inc. (SYRE)Equibles does not estimate personal net worth.
About Michael Henderson
Michael Henderson is recorded as Board Member at Spyre Therapeutics, Inc. (SYRE). The newest filing on record that lists Michael Henderson as Board Member at Spyre Therapeutics, Inc. (SYRE) is dated April 10, 2026. Spyre Therapeutics, Inc. reported in an 8-K filed June 23, 2023 that Michael Henderson was appointed Board, effective June 22, 2023. Spyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spyre Therapeutics, Inc. includes Cameron Turtle (CEO, COO and Board Member), Cameron Turtle, DPhil (CEO and Board Member), James Kastenmayer (CEO) and 7 others.
“on June 22, 2023, effective immediately after the Effective Time, Peter Harwin, Tomas Kiselak and Michael Henderson were appointed to the Board as directors.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 10, 2026
Company network
Leadership on record at Spyre Therapeutics, Inc.
- Cameron Turtle CEO, COO, Board Member
- Cameron Turtle, DPhil CEO, Board Member
- James Kastenmayer CEO
- Jeffrey M. Goldberg CEO
- Scott Burrows CFO, Chief Accounting Officer
- Heidy Abreu King-Jones General Counsel
- Jonathan Alspaugh Chief Accounting Officer
- Steven Weber Chief Accounting Officer
- Jeffrey Albers Board Member
- Laurie Stelzer Board Member